Bafna Pharmaceuticals Limited (BAFNAPH) — Free Cash Flow Generation Index
Bafna Pharmaceuticals Limited (BAFNAPH) has a Free Cash Flow Generation Index of -0.76x as of September 2025. Free cash flow of Rs-71.04 Million represents -1% of operating cash flow (Rs93.12 Million). See Bafna Pharmaceuticals Limited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Bafna Pharmaceuticals Limited Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Bafna Pharmaceuticals Limited across 9 annual periods. Explore how well can Bafna Pharmaceuticals Limited service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Bafna Pharmaceuticals Limited (2007–2025)
Year-by-year Free Cash Flow Generation Index for Bafna Pharmaceuticals Limited. For the full company profile including market capitalisation, see BAFNAPH stock market capitalisation.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | Rs-23.31 Million | Rs195.29 Million | Rs218.60 Million | ▲ +81.4% |
| 2024 | -0.64x | Rs-60.93 Million | Rs94.85 Million | Rs155.78 Million | ▲ +2.6% |
| 2023 | -0.66x | Rs-32.66 Million | Rs49.52 Million | Rs82.19 Million | ▼ -393.3% |
| 2022 | 0.22x | Rs21.87 Million | Rs97.28 Million | Rs75.41 Million | ▲ +114.7% |
| 2016 | -1.53x | Rs-13.96 Million | Rs9.11 Million | Rs23.07 Million | ▼ -668.4% |
| 2015 | 0.27x | Rs28.75 Million | Rs106.65 Million | Rs77.90 Million | ▲ +395.6% |
| 2014 | -0.09x | Rs-1.46 Million | Rs16.06 Million | Rs17.53 Million | ▼ -109.7% |
| 2013 | 0.94x | Rs345.05 Million | Rs366.32 Million | Rs21.28 Million | ▲ +210.7% |
| 2007 | -0.85x | Rs-85.96 Million | Rs101.06 Million | Rs187.01 Million | — |